Regeneration Technologies, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Alachua, Florida human allograft tissue implant processor amends lawsuit against Musculoskeletal Transplant Foundation (MTF) to add charges that MTF made false and misleading claims that its human allograft tissue is sterile. RTI originally filed suit against the non-profit tissue provider in the U.S. District Court for the Northern District of Florida in Gainesville alleging that an MTF advertising campaign disparaged RTI products as unsafe. The suit charges MTF with false advertising, unfair competition and intentional interference with RTI's business relationships (1"The Gray Sheet" June 18, 2001, In Brief)
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.